Fig. 2From: Immuno-psychiatry: an agenda for clinical practice and innovative researchExample of the putative molecular link between medical comorbidities in psychotic disorders. An alteration of the glutamatergic NMDA receptor signalling, proposed to be central in the aetiology of psychotic disorders, may have varying impact in the various organs of these patientsBack to article page